E Fund Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $393K | Sell |
5,020
-802
| -14% | -$62.7K | 0.02% | 262 |
|
|
2025
Q1 | $422K | Sell |
5,822
-24
| -0.4% | -$1.74K | 0.02% | 244 |
|
|
2024
Q4 | $433K | Buy |
5,846
+2,273
| +64% | +$168K | 0.02% | 246 |
|
|
2024
Q3 | $236K | Buy |
3,573
+681
| +24% | +$44.9K | 0.01% | 293 |
|
|
2024
Q2 | $267K | Buy |
2,892
+22
| +0.8% | +$2.03K | 0.01% | 251 |
|
|
2024
Q1 | $274K | Sell |
2,870
-63
| -2% | -$6.02K | 0.02% | 290 |
|
|
2023
Q4 | $224K | Buy |
+2,933
| New | +$224K | 0.01% | 265 |
|
|
2023
Q3 | – | Sell |
-2,126
| Closed | -$201K | – | 301 |
|
|
2023
Q2 | $201K | Sell |
2,126
-323
| -13% | -$30.5K | 0.02% | 278 |
|
|
2023
Q1 | $203K | Buy |
+2,449
| New | +$203K | 0.01% | 296 |
|
|
2022
Q4 | – | Sell |
-2,575
| Closed | -$213K | – | 341 |
|
|
2022
Q3 | $213K | Buy |
2,575
+278
| +12% | +$23K | 0.02% | 296 |
|
|
2022
Q2 | $218K | Buy |
2,297
+39
| +2% | +$3.7K | 0.02% | 286 |
|
|
2022
Q1 | $266K | Sell |
2,258
-127
| -5% | -$15K | 0.01% | 241 |
|
|
2021
Q4 | $309K | Sell |
2,385
-30
| -1% | -$3.89K | 0.01% | 209 |
|
|
2021
Q3 | $273K | Buy |
+2,415
| New | +$273K | 0.01% | 196 |
|